| Dr Kenneth Patrick Buckley, PHARMD | |
|
1175 Madison Ave, Mankato, MN 56001-5227 | |
| (507) 625-1791 | |
| (507) 625-9262 |
| Full Name | Dr Kenneth Patrick Buckley |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1175 Madison Ave, Mankato, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013538818 | NPI | - | NPPES |
| 120201 | Other | MN | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 120201 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Patrick Buckley, PHARMD 1175 Madison Ave, Mankato, MN 56001-5227 Ph: (507) 625-1791 | Dr Kenneth Patrick Buckley, PHARMD 1175 Madison Ave, Mankato, MN 56001-5227 Ph: (507) 625-1791 |
News Archive
A new economic analysis, published online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexilate is cost-effective compared to current treatment options, particularly in real-world clinical practice.
Researchers examined the antibody responses in symptomatic and asymptomatic individuals recovered from COVID-19 to see if there was a discernable difference in their humoral immune responses and long-term protection from reinfection with SARS-CoV-2.
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius released the following statement today on WellPoint's announcement that it intends to end the practice of rescinding patients' coverage in advance of the Affordable Care Act's requirement that insurers stop this practice starting this fall. WellPoint's announcement comes after Secretary Sebelius sent a letter on April 22 urging the company to immediately stop the practice of rescinding coverage for patients who become ill.
Infertility is an unexpected obstacle for many people, and the journey can be unpredictable. Patients may find themselves at a crossroads after multiple failed attempts with fertility treatments, and begin to look for other options.
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
› Verified 5 days ago
Daniel Fandrich, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1270 E Madison Ave, Mankato, MN 56001 Phone: 507-388-1315 Fax: 507-388-6369 | |
Bradley Dean Borresen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Adams St, Mankato, MN 56001 Phone: 507-625-7565 | |
Jairus Matthew Mcbride, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 S Riverfront Dr, Mankato, MN 56001 Phone: 507-345-5091 Fax: 507-625-4735 | |
Jenna Jackson, PHARM.D., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-594-2999 | |
Carol Daley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Riverfront Dr, Mankato, MN 56001 Phone: 507-345-5066 | |
Dr. Katelyn Rebecca Marie Neverman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 |